Avanos Medical (AVNS) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
12 Mar, 2026Voting matters and shareholder proposals
Election of eight directors to serve until the 2027 Annual Meeting, with all nominees recommended for approval.
Ratification of Deloitte & Touche LLP as independent registered public accounting firm for 2026.
Advisory vote to approve named executive officer compensation.
Approval of an amendment to the 2021 Long Term Incentive Plan to permit awards to outside directors.
Board of directors and corporate governance
Eight director nominees are presented for election, each recommended by the board.
Executive compensation and say-on-pay
Advisory vote scheduled for shareholder approval of named executive officer compensation.
Proposal to amend the 2021 Long Term Incentive Plan to include outside directors as eligible award recipients.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Avanos Medical
- Proxy covers director elections, pay, auditor ratification, and ESG progress, with all proposals supported.AVNS
Proxy Filing12 Mar 2026 - Focused on core growth, tariff mitigation, and innovation to drive strong financial performance.AVNS
The Citizens Life Sciences Conference 202611 Mar 2026 - FY25 net sales hit $701M; 2026 targets $700–$720M sales and $0.90–$1.10 EPS.AVNS
Q4 202524 Feb 2026 - Q2 2024 saw strong sales, margin gains, and robust outlook led by Digestive Health.AVNS
Q2 20242 Feb 2026 - Q3 2024 sales were $170.4M, Digestive Health grew, Pain Management fell, and leadership changed.AVNS
Q3 202417 Jan 2026 - Strategy, innovation, and M&A support a $1B revenue vision by 2030.AVNS
44th Annual J.P. Morgan Healthcare Conference14 Jan 2026 - Enteral Feeding growth and cash flow strong, but impairment and HA pricing weigh on outlook.AVNS
Q4 202423 Dec 2025 - Annual meeting to vote on directors, auditor, executive pay, and equity plan amendment.AVNS
Proxy Filing2 Dec 2025 - Key votes include director elections, auditor ratification, and expanding the incentive plan.AVNS
Proxy Filing2 Dec 2025